Remedy Entertainment Oyj Statistics

Total Valuation

HEL:REMEDY has a market cap or net worth of EUR 200.51 million. The enterprise value is 190.51 million.

Market Cap	200.51M
Enterprise Value	190.51M

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

HEL:REMEDY has 13.64 million shares outstanding. The number of shares has increased by 0.56% in one year.

Current Share Class	13.64M
Shares Outstanding	13.64M
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	44.96%
Owned by Institutions (%)	8.30%
Float	5.50M

Valuation Ratios

The trailing PE ratio is 313.79 and the forward PE ratio is 76.68.

PE Ratio	313.79
Forward PE	76.68
PS Ratio	3.35
PB Ratio	2.88
P/TBV Ratio	2.51
P/FCF Ratio	17.28
P/OCF Ratio	43.51
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.73, with an EV/FCF ratio of 16.42.

EV / Earnings	298.14
EV / Sales	3.18
EV / EBITDA	20.73
EV / EBIT	103.37
EV / FCF	16.42

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.25.

Current Ratio	3.93
Quick Ratio	3.93
Debt / Equity	0.25
Debt / EBITDA	1.91
Debt / FCF	1.51
Interest Coverage	1.44

Financial Efficiency

Return on equity (ROE) is 0.95% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	0.95%
Return on Assets (ROA)	1.23%
Return on Invested Capital (ROIC)	1.47%
Return on Capital Employed (ROCE)	2.13%
Revenue Per Employee	155,405
Profits Per Employee	1,660
Employee Count	367
Asset Turnover	0.64
Inventory Turnover	n/a

Taxes

In the past 12 months, HEL:REMEDY has paid 988,000 in taxes.

Income Tax	988,000
Effective Tax Rate	60.73%

Stock Price Statistics

The stock price has decreased by -16.84% in the last 52 weeks. The beta is 0.77, so HEL:REMEDY's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-16.84%
50-Day Moving Average	15.66
200-Day Moving Average	14.84
Relative Strength Index (RSI)	40.07
Average Volume (20 Days)	8,463

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HEL:REMEDY had revenue of EUR 59.83 million and earned 639,000 in profits. Earnings per share was 0.05.

Revenue	59.83M
Gross Profit	45.69M
Operating Income	1.84M
Pretax Income	1.63M
Net Income	639,000
EBITDA	7.81M
EBIT	1.84M
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 27.56 million in cash and 17.55 million in debt, giving a net cash position of 10.01 million or 0.73 per share.

Cash & Cash Equivalents	27.56M
Total Debt	17.55M
Net Cash	10.01M
Net Cash Per Share	0.73
Equity (Book Value)	69.57M
Book Value Per Share	5.10
Working Capital	31.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.61 million and capital expenditures 7.00 million, giving a free cash flow of 11.60 million.

Operating Cash Flow	4.61M
Capital Expenditures	7.00M
Free Cash Flow	11.60M
FCF Per Share	0.85

Full Cash Flow Statement

Margins

Gross margin is 76.36%, with operating and profit margins of 3.08% and 1.07%.

Gross Margin	76.36%
Operating Margin	3.08%
Pretax Margin	2.72%
Profit Margin	1.07%
EBITDA Margin	13.06%
EBIT Margin	3.08%
FCF Margin	19.39%

Dividends & Yields

HEL:REMEDY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	n/a
Earnings Yield	0.32%
FCF Yield	5.79%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HEL:REMEDY has an Altman Z-Score of 5.74 and a Piotroski F-Score of 7.

Altman Z-Score	5.74
Piotroski F-Score	7